Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas

Clinical trial NCT06865677 · TERMINATED

Trial details

NCT number: NCT06865677
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Platinum Resistant Epithelial Ovarian Carcinoma Recurrent Epithelial Endometrial Carcinoma Recurrent Epithelial Cervical Carcinoma

Start date: 2025-06-09
Primary completion: 2025-07-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.